Article
K-Ras, intestinal homeostasis and colon cancer.
Current clinical pharmacology - 1 Jan 2015
Goel Sanjay, Huang Jie, Klampfer Lidija
Abstract excerpt
Activating Ras mutations, present in about 20% of human cancers, compromise the GTPase activity of Ras and therefore trigger accumulation of Ras in the GTP-bound state. Among the three family members, K-Ras, H-Ras and N-Ras, K-Ras is the most frequently mutated gene, with 30-50% of colon cancer patients harboring activating K-Ras mutations. Oncogenic mutations of K-Ras have been found at codons 12, 13, 61 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
